Large deal wins to offset pressure in legacy business Despite winning large deals over the past few quarters, the company is unable to register healthy growth mainly due to pressure on the traditional business, auto in manufacturing, softness in BFSI and project volatility in healthcare. However, going forward, the large deal wins in communication, healthy pipeline in BFSI and healthcare are expected to help improve growth in coming quarters. The company has won US$475 million deals across communication and enterprise segment in Q1FY20. This, coupled with...